[Clinical efficacy of cefixime (results of multicenter trials)].

Multicentre trials of cefixime (Cefspan, Fujisawa Pharmaceutical Co., Ltd., Japan) were performed in 1992.

[Study of circadian rhythm of bronchial patency for timely correction and evaluation of the effectiveness of inhalation powder forms of salbutamol in children with bronchial asthma].

A study was made of the circadian rhythms of bronchial patency for ++timely correction and dynamic estimation of the efficacy of powdered inhalation salbutamol (ventodisc) in 30 children aged 7-15 years suffering from persistent recurrent bronchial asthma. The treatment with ventodisc was carried out after basic therapy (euphylline or theopec and/or becotid). During 1 week the children inhaled the drug only at the moments of attacks of obstructed respiration.

[The results of the therapeutic monitoring of piracetam in parturients and newborn infants].

Overall 30 women in childbirth with preeclampsia and fetoplacental dysfunction received piracetam solution which was given initially in a dose of 5 g by intravenous drip, rapidly since the onset of labour and then every 2 hours till the end of labour in a dose of 2 g by jet injection. This made it possible to increase fetus resistance to hypoxic conditions. The concentrations of piracetam within the range of 60-80 g/l in the blood of women in childbirth should be viewed as minimum therapeutic.